TrialJapanese journal of clinical oncology2020

Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan.

Yuichiro Ohe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.